PRGO Q2 2022 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena

PRGOPerrigo Company plc

$1B

Q2 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.1B+14.3% YoY

Gross Profit

$372M33.2% margin

Operating Income

-$7M-0.6% margin

Net Income

-$65M-5.8% margin

EPS (Diluted)

$-0.48

QoQ Revenue Growth

+4.4%

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$55M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$10.9B

Total Liabilities

$6.1B

Stockholders' Equity

$4.8B

Cash & Equivalents

$485M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.1B	$981M	+14.3%
Gross Profit	$372M	$349M	+6.6%
Operating Income	-$7M	-$126M	+94.5%
Net Income	-$65M	-$58M	-12.8%

Revenue Segments

Consumer Self-Care Americas

$728M65%

Consumer Self-Care International

$394M35%

Geographic Segments

UNITED STATES

$718M64%

Europe

$382M34%

Other Geographical Areas

$22M2%

IRELAND

$7M1%